Corticotropin releasing factor-1 receptor antagonists: Synthesis and structure-activity relationships of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives.

被引:0
|
作者
Hartz, RA
Nanda, KK
Ingalls, CL
Ahuja, VT
Molski, TF
Mattson, GK
Zhang, G
Wong, H
Zaczek, R
Trainor, GL
Gilligan, PJ
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Discovery Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Neurosci Biol Dept, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Metab & Pharmacokinet Dept, Wallingford, CT 06492 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
301-MEDI
引用
收藏
页码:U62 / U62
页数:1
相关论文
共 50 条
  • [1] Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6H-purin-6-one and 3,7-dihydro-1H-purine-2,6-dione derivatives as corticotropin-releasing factor, receptor antagonists
    Hartz, RA
    Nanda, KK
    Ingalls, CL
    Ahuja, VT
    Molski, TF
    Zhang, G
    Wong, H
    Peng, Y
    Kelley, M
    Lodge, NJ
    Zaczek, R
    Gilligan, PJ
    Trainor, GL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (19) : 4741 - 4754
  • [2] Monoclinic polymorph of 3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione
    Stepanovs, Dmitrijs
    Mishnev, Anatoly
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2851 - +
  • [3] STRUCTURE OF ENPROFYLLINE - 3,7-DIHYDRO-3-PROPYL-1H-PURINE-2,6-DIONE
    STALHANDSKE, C
    SLOT, HJB
    BEURSKENS, PT
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1985, 41 (OCT) : 1517 - 1520
  • [4] OPTIMIZATION OF PARTIAL ALKYLATION OF 3-METHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE AND ITS 8-ALKYL DERIVATIVES
    RYBAR, A
    BASNAKOVA, G
    STANOVA, A
    CHEMICAL PAPERS, 1993, 47 (01): : 38 - 40
  • [5] Photochemistry synthesis.: Part 1:: Syntheses of xanthine derivatives by photolysis of 1-(5′-oxohexyl)-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione (pentoxifylline):: an ambident chromophore
    Han, Ze
    Bonnet, Susan L.
    van der Westhuizen, Jan H.
    TETRAHEDRON, 2008, 64 (11) : 2619 - 2625
  • [6] Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists
    Hartz, Richard A.
    Ahuja, Vijay T.
    Schmitz, William D.
    Molski, Thaddeus F.
    Mattson, Gail K.
    Lodge, Nicholas J.
    Bronson, Joanne J.
    Macor, John E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 1890 - 1894
  • [7] Crystal structure of 3,7-dimethyl-1-(5-oxohexyl)-3, 7-dihydro-1H-purine-2,6-dione 4-hydroxybenzoic acid, C20H24N4O6
    Li, Peizhe
    Liu, Lei
    Lou, Benyong
    Zhan, Hongbing
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2020, 235 (03): : 599 - 600
  • [8] Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists
    Dzierba, CD
    Takvorian, AG
    Rafalski, M
    Kasireddy-Polam, P
    Wong, H
    Molski, TF
    Zhang, G
    Li, YW
    Lelas, S
    Peng, Y
    McElroy, JF
    Zaczek, RC
    Taub, RA
    Combs, AP
    Gilligan, PJ
    Trainor, GL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (23) : 5783 - 5790
  • [9] STUDIES ON XANTHINE DERIVATIVES .2. SYNTHESIS OF 1,2,3,7-TETRAHYDRO-6H-PURIN-6-ONES FROM XANTHINE HYDROLYZATES
    OHSAKI, T
    KURIKI, T
    UEDA, T
    SAKAKIBARA, J
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (01) : 36 - 50
  • [10] Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists
    Lowe, RF
    Nelson, J
    Dang, TN
    Crowe, PD
    Pahuja, A
    McCarthy, JR
    Grigoriadis, DE
    Conlon, P
    Saunders, J
    Chen, C
    Szabo, T
    Chen, TK
    Bozigian, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) : 1540 - 1549